Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase Life Science Investing News
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE Life Science Investing News
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone SmartNews
U.S. FDA Approves EMRELIS for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer With High c-Met Protein Overexpression Pharmaceutical Investing
AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas Pharmaceutical Investing
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference Life Science Investing News
